In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Ben Lincoln of Potter Clarkson says monitoring the patent filings of competitors is a worthwhile strategic practice that can ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

Lord Justice Jacob noted the temptation to treat patent-eligible subject matter like an elephant: “you know it when you see ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

Sports betting giants DraftKings Inc. and FanDuel Inc. were hit with new lawsuits accusing them of infringing online and ...

Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...

C-Bond Systems plans to acquire nutraceutical gummy leaders Gummy USA, SureDose, and Creative Manufacturing, boosting precision dosing innovation.

Axsome Therapeutics (AXSM) stock rallied 15% on news the company has settled patent litigation with Teva (TEVA) over a ...

Desmopressin is approved in various forms, but these do not meet the paediatric need for precise, titratable and small doses.

The US Patent & Trademark Office (PTO) issued additional guidance on the contribution of artificial intelligence (AI) in its January 2025 AI ...